2,025 Shares in Electromed, Inc. $ELMD Acquired by State of Wyoming

State of Wyoming acquired a new stake in Electromed, Inc. (NYSE:ELMD) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,025 shares of the company’s stock, valued at approximately $48,000.

Several other institutional investors and hedge funds have also made changes to their positions in ELMD. Northern Trust Corp lifted its position in shares of Electromed by 14.1% in the fourth quarter. Northern Trust Corp now owns 65,350 shares of the company’s stock valued at $1,931,000 after acquiring an additional 8,086 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Electromed in the fourth quarter valued at $703,000. Algert Global LLC purchased a new stake in shares of Electromed in the fourth quarter valued at $323,000. Ameriprise Financial Inc. lifted its position in shares of Electromed by 49.1% in the fourth quarter. Ameriprise Financial Inc. now owns 42,072 shares of the company’s stock valued at $1,243,000 after acquiring an additional 13,861 shares in the last quarter. Finally, BNP Paribas Financial Markets purchased a new stake in shares of Electromed in the fourth quarter valued at $342,000. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Price Performance

Shares of NYSE:ELMD opened at $26.61 on Wednesday. The firm has a market capitalization of $222.17 million, a PE ratio of 35.48 and a beta of 0.54. The business has a 50-day moving average of $20.32 and a two-hundred day moving average of $21.86. Electromed, Inc. has a 12 month low of $16.58 and a 12 month high of $35.56.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on ELMD shares. Loop Capital set a $36.00 price objective on Electromed in a research report on Wednesday, August 27th. Lake Street Capital assumed coverage on Electromed in a research note on Wednesday, August 27th. They issued a “buy” rating and a $36.00 target price for the company. Roth Capital upped their target price on Electromed from $29.00 to $35.00 and gave the company a “buy” rating in a research note on Wednesday, August 27th. Finally, B. Riley upgraded Electromed to a “strong-buy” rating in a research note on Thursday, May 15th. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. According to MarketBeat.com, Electromed presently has an average rating of “Buy” and a consensus price target of $36.25.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.